Scott A. Kelly - 31 Jul 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
CMO, Director
Signature
/s/ Antonio Migliarese, Attorney-In-Fact
Issuer symbol
CYDY
Transactions as of
31 Jul 2022
Transactions value $
$0
Form type
4
Date filed
04 Aug 2022, 16:06
Previous filing
19 Jul 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYDY Common Stock Award $0 +7.49K +0.36% $0.00 2.07M 31 Jul 2022 Direct F1
holding CYDY Common Stock 782K 31 Jul 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Remarks:

EX 24 - Power of Attorney